EndoChoice CEO Mark Gilreath bought 20,000 shares of the company's stock, according to a South Florida Hedge Fund Managers report.
Here are five takeaways:
1. The shares were purchased at an average price of $5.06 per share, for a total value of $101,200.
2. The CEO now owns 753,250 shares of the company's stock.
3. EndoChoice has a 52-week low of $3.70 and a 52-week high of $19.69.
4. The company's 50-day moving average price is $4.81 and its 200-day moving average price is $8.81.
5. The company's market capitalization is $143.81 million.